beta-alanine and metformin

beta-alanine has been researched along with metformin in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bergman, A; Erion, DM; Kazierad, DJ; Lee, DS; Rolph, T; Somayaji, V; Tan, B	1
Bugáňová, M; Haluzík, M; Holubová, M; Kaválková, P; Kuneš, J; Kuzma, M; Maletínská, L; Pelantová, H; Šedivá, B; Sýkora, D; Železná, B; Zemenová, J	1
Bergman, AJ; Calle, RA; Chidsey, K; Kazierad, DJ; Somayaji, VR	1

Trials

2 trial(s) available for beta-alanine and metformin

Article	Year
Effects of multiple ascending doses of the glucagon receptor antagonist PF-06291874 in patients with type 2 diabetes mellitus. Diabetes, obesity & metabolism, 2016, Volume: 18, Issue:8 Topics: Adult; Aged; Alanine Transaminase; Amino Acids; Aspartate Aminotransferases; beta-Alanine; Blood Glucose; C-Peptide; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Fasting; Female; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Pyrazoles; Receptors, Glucagon; Sulfonylurea Compounds	2016
Efficacy and safety of the glucagon receptor antagonist PF-06291874: A 12-week, randomized, dose-response study in patients with type 2 diabetes mellitus on background metformin therapy. Diabetes, obesity & metabolism, 2018, Volume: 20, Issue:11 Topics: Adolescent; Adult; Aged; beta-Alanine; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Metformin; Middle Aged; Pyrazoles; Receptors, Glucagon; Young Adult	2018

Article

Year

Effects of multiple ascending doses of the glucagon receptor antagonist PF-06291874 in patients with type 2 diabetes mellitus.

Diabetes, obesity & metabolism, 2016, Volume: 18, Issue:8

Topics: Adult; Aged; Alanine Transaminase; Amino Acids; Aspartate Aminotransferases; beta-Alanine; Blood Glucose; C-Peptide; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Fasting; Female; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Pyrazoles; Receptors, Glucagon; Sulfonylurea Compounds

2016

Efficacy and safety of the glucagon receptor antagonist PF-06291874: A 12-week, randomized, dose-response study in patients with type 2 diabetes mellitus on background metformin therapy.

Diabetes, obesity & metabolism, 2018, Volume: 20, Issue:11

Topics: Adolescent; Adult; Aged; beta-Alanine; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Metformin; Middle Aged; Pyrazoles; Receptors, Glucagon; Young Adult

2018

Other Studies

1 other study(ies) available for beta-alanine and metformin

Article	Year
Urinary metabolomic profiling in mice with diet-induced obesity and type 2 diabetes mellitus after treatment with metformin, vildagliptin and their combination. Molecular and cellular endocrinology, 2016, 08-15, Volume: 431 Topics: Adamantane; Animals; beta-Alanine; Diabetes Mellitus, Type 2; Diet; Glucose Tolerance Test; Hypoglycemic Agents; Male; Metabolomics; Metformin; Mice; Mice, Inbred C57BL; Nitriles; Obesity; Pyridones; Pyrrolidines; Vildagliptin	2016

Article

Year

Urinary metabolomic profiling in mice with diet-induced obesity and type 2 diabetes mellitus after treatment with metformin, vildagliptin and their combination.

Molecular and cellular endocrinology, 2016, 08-15, Volume: 431

Topics: Adamantane; Animals; beta-Alanine; Diabetes Mellitus, Type 2; Diet; Glucose Tolerance Test; Hypoglycemic Agents; Male; Metabolomics; Metformin; Mice; Mice, Inbred C57BL; Nitriles; Obesity; Pyridones; Pyrrolidines; Vildagliptin

2016